muc1 peptide Mucin 1 (MUC1 - mt2-peptide-nasal is used for blocking the activity of MUC1 antibody Understanding the Significance of the MUC1 Peptide in Cancer Research and Therapy

mt2-melanotan-ii-10mg-peptide-for-sale The MUC1 peptide represents a crucial area of study within cancer research, particularly due to its aberrant expression on the surface of various epithelial-derived tumor tissuesMUC1 (Mucin 1) proteinis a type 1 transmembrane glycoprotein characterized by a large extracellular domain. This domain contains a variable number (up to 120) .... This transmembrane mucin glycoprotein, also known by aliases such as MAM6 and EMA, plays a significant role in cellular processes and its altered presentation in cancer cells makes it a compelling target for therapeutic interventions. Research has extensively explored the potential of MUC1 peptides in developing novel cancer treatments, with a particular focus on their anti-tumor activity and immunogenicity.MUC1 Peptide Vaccination in Patients with Advanced ...

MUC1, encoded by the MUC1 gene in humans, is a heterodimer transmembrane protein belonging to the mucin family. It is cleaved into two distinct chains, contributing to its complex structure and function. Mucins are O-glycosylated proteins that are essential for forming protective barriers in various tissues. However, in the context of cancer, Mucin-1 (MUC1) often exhibits abnormal glycosylation patterns and is overexpressed, distinguishing it from its expression in normal epithelial cells. This overabundance of MUC1 on the surface of adenocarcinomas, including those of the pancreas, breast, and bladder tumors, makes it a valuable biomarker and therapeutic target.

A significant avenue of research involves the development of MUC1 peptide vaccines. These vaccines are often comprised of a synthetic peptide derived from the mucin 1 (MUC1) antigen with the aim of stimulating an immune response against cancer cells. Studies have investigated the immunogenicity of MUC1 peptides, with findings suggesting that these peptides are the target for anti-MUC1 antibodies作者：CM Cameron·2024·被引用次数：2—We recently assessed in two clinical trials in a preventative setting whether immunity induced with aMUC1 peptidevaccine could reduce high colon cancer risk.. These antibodies can demonstrate differential reactions on cancer cells compared to normal tissues, highlighting the specificity achievable with MUC1 peptide-based approaches. For instance, the MUC1 (12-20) peptide, characterized by its tandem repeat sequence, is a focus of such investigations.MUC1 peptide STAPPVHNV (HLA-A*0201) is a single peptide for stimulation of T cells. The peptide from Mucin 1 (MUC1) is synthesized as it is presented by the ...

The potential of MUC1 peptides in cancer therapy is multifaceted. Research has demonstrated that intracellular MUC1 peptides possess significant anti-tumor activity and hold important clinical applications in cancer treatment. Furthermore, clinical trials have been conducted to evaluate the safety and immunogenicity of MUC1 peptide vaccines.MUC1 Peptide Pool, human | LB02522 These trials have explored various formulations, including liposomal vaccines like BLP25, and combinations with adjuvants such as Poly-ICLC to enhance the immune response.TheHUMAN MUC1 Peptide Poolby peptides&elephants is a highly reliable, quality-controlled, overlapping peptide pool covering the complete human Mucin‑1 ... The 100mer MUC1 peptide has been a component in some of these studies, aiming to induce an immune response against the tumor-associated antigen.

Specific MUC1 peptide sequences, such as MUC1 peptide STAPPVHNV (HLA-A*0201), are synthesized for their ability to stimulate T cells, indicating their role in cellular immunity against cancer. The identification of MUC1 peptide epitopes associated with different MHC (Major Histocompatibility Complex) molecules further refines the understanding of how the immune system recognizes and targets MUC1-expressing cancer cells. Researchers have explored MUC1 peptide pools, which are overlapping peptide sequences covering the entire human Mucin-1 protein, to provide a comprehensive antigenic stimulus.MUC1 peptide epitopes associated with five different H‐2 ...

Beyond therapeutic vaccines, MUC1 peptides also find application in diagnostic and research settingsMUC1 Peptide - Cat. No. 7451P. MUC1 blocking peptides are utilized as controls in assays to ensure the specificity of MUC1 antibodies. These MUC1 Antibody Blocking Peptides are crucial for validating experimental results and confirming that antibody binding is indeed directed towards the intended target. Examples include specific blocking peptides designed to inhibit the activity of particular MUC1 antibodies.

The exploration of MUC1 peptide applications extends to various cancer types. For example, MUC1 peptide vaccine in advanced pancreatic and bile duct cancers has been a subject of clinical investigationAbstract. Purpose: To assess whetherMUC1 peptide vaccineproduces an immune response and prevents subsequent colon adenoma formation.. Similarly, studies have assessed whether a MUC1 peptide vaccine can reduce the risk of colon cancer. The consistent over-expression of MUC1 across a range of epithelial cancers underscores its broad therapeutic potential.Human Mucin-1 (MUC1) Peptideis a synthetic Human Peptide. Target, Mucin-1 (MUC1). Research Area, Tumor Immunity, Infection Immunity, Pulmonology.

In summary, the MUC1 peptide is a critical element in the ongoing fight against cancer. From its role as a tumor-associated antigen to its utilization in developing innovative vaccines and diagnostic tools, the MUC1 peptide continues to be a focal point of scientific inquiry, offering promising avenues for improved cancer detection and treatment strategiesMUC1 Vaccines, Comprised of Glycosylated or Non .... The ongoing research into MUC1 and its associated peptides, including the investigation of MUC1, tandem repeat fragment, and various MUC1 blocking peptides, signifies a dedicated effort to harness the power of this molecule for the benefit of patientsMUC1 peptide epitopes associated with five different H‐2 ....